View Older Stories View More Recent Stories

Nov 7, 2022 08:00AM Oyster Point Pharma, a Leading Ophthalmology-Focused Biopharmaceutical Company, to be Acquired by Viatris
Nov 7, 2022 08:00AM Oyster Point Pharma, a Leading Ophthalmology-Focused Biopharmaceutical Company, to be Acquired by Viatris
Nov 2, 2022 04:02PM Oyster Point Pharma To Report Third Quarter 2022 Financial Results On November 10, 2022
Nov 2, 2022 04:02PM Oyster Point Pharma To Report Third Quarter 2022 Financial Results On November 10, 2022
Nov 2, 2022 08:00AM Oyster Point Pharma, Inc., Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 2, 2022 08:00AM Oyster Point Pharma, Inc., Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 4, 2022 08:00AM Oyster Point Pharma, Inc., Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 4, 2022 08:00AM Oyster Point Pharma, Inc., Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 27, 2022 08:00AM Oyster Point Pharma to Present New Scientific Analyses at World Cornea Congress VIII
Sep 27, 2022 08:00AM Oyster Point Pharma to Present New Scientific Analyses at World Cornea Congress VIII
Sep 7, 2022 05:36PM Oyster Point Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 7, 2022 05:36PM Oyster Point Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 25, 2022 08:00AM Oyster Point Pharma to Present Analyses at the Women in Ophthalmology Summer Symposium
Aug 25, 2022 08:00AM Oyster Point Pharma to Present Analyses at the Women in Ophthalmology Summer Symposium
Aug 17, 2022 08:00AM Oyster Point Pharma Inc. (OYST) Announces Coverage of TYRVAYA By the Largest Medicare Pharmacy Benefit Manager
Aug 17, 2022 08:00AM Oyster Point Pharma Announces TYRVAYA® To Be Covered By the Largest Medicare Pharmacy Benefit Manager
Aug 17, 2022 08:00AM Oyster Point Pharma Announces TYRVAYA® To Be Covered By the Largest Medicare Pharmacy Benefit Manager
Aug 15, 2022 08:00AM Oyster Point Pharma To Attend H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference on August 17, 2022
Aug 15, 2022 08:00AM Oyster Point Pharma To Attend H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference on August 17, 2022
Aug 11, 2022 04:01PM Oyster Point Pharma Reports Second Quarter 2022 Financial Results and Recent Business Highlights
Aug 11, 2022 04:01PM Oyster Point Pharma Reports Second Quarter 2022 Financial Results and Recent Business Highlights
Aug 8, 2022 04:03PM Oyster Point Pharma To Report Second Quarter 2022 Financial Results On August 11, 2022
Aug 8, 2022 04:03PM Oyster Point Pharma To Report Second Quarter 2022 Financial Results On August 11, 2022
Jul 27, 2022 07:03AM Oyster Point Pharma Inc. (OYST) Announces Expanded Patient Access to TYRVAYA
Jul 27, 2022 07:00AM Oyster Point Pharma Announces Expanded Patient Access to TYRVAYA®
Jul 27, 2022 07:00AM Oyster Point Pharma Announces Expanded Patient Access to TYRVAYA®
Jun 28, 2022 04:07PM Oyster Point Pharma Inc. (OYST) to Implement Operating Expense Streamlining Plan
Jun 28, 2022 04:05PM Oyster Point Pharma Announces Operating Expense Streamlining Plan
Jun 28, 2022 04:05PM Oyster Point Pharma Announces Operating Expense Streamlining Plan
Jun 15, 2022 07:55AM Oyster Point Pharma Inc. (OYST) Research Selected for Top 5 Poster Session at American Optometric Association's Optometry's Meeting
Jun 15, 2022 07:55AM Oyster Point Pharma Research Selected for Top 5 Poster Session at American Optometric Association's Optometry's Meeting®
Jun 15, 2022 07:55AM Oyster Point Pharma Research Selected for Top 5 Poster Session at American Optometric Association's Optometry's Meeting®
May 5, 2022 04:01PM Oyster Point Pharma Reports First Quarter 2022 Financial Results and Recent Business Highlights
May 5, 2022 04:01PM Oyster Point Pharma Reports First Quarter 2022 Financial Results and Recent Business Highlights
May 3, 2022 04:01PM Oyster Point Pharma To Report First Quarter 2022 Financial Results On May 5, 2022
May 3, 2022 04:01PM Oyster Point Pharma To Report First Quarter 2022 Financial Results On May 5, 2022
Apr 27, 2022 08:00AM Oyster Point Pharma to Present New Analyses at the Association for Research in Vision and Ophthalmology (ARVO) 2022
Apr 27, 2022 08:00AM Oyster Point Pharma to Present New Analyses at the Association for Research in Vision and Ophthalmology (ARVO) 2022
Apr 19, 2022 08:00AM Oyster Point Pharma to Present New Clinical Data at the American Society of Cataract and Refractive Surgery (ASCRS) 2022
Apr 19, 2022 08:00AM Oyster Point Pharma to Present New Clinical Data at the American Society of Cataract and Refractive Surgery (ASCRS) 2022
Mar 17, 2022 08:05AM Oyster Point Pharma Inc. (OYST) Announces Retirement of William J. Link From Board of Directors
Mar 17, 2022 08:00AM Oyster Point Pharma Announces Retirement of William J. Link From Board of Directors
Mar 17, 2022 08:00AM Oyster Point Pharma Announces Retirement of William J. Link From Board of Directors
Mar 1, 2022 04:05PM Oyster Point Pharma to Participate in the Cowen 42nd Annual Health Care Conference
Mar 1, 2022 04:05PM Oyster Point Pharma to Participate in the Cowen 42nd Annual Health Care Conference
Feb 24, 2022 04:01PM Oyster Point Pharma Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights
Feb 24, 2022 04:01PM Oyster Point Pharma Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights
Feb 22, 2022 07:02AM Oyster Point Pharma Inc. (OYST) Announces TYRVAYA Nasal Spray Now Covered by Express Scripts
Feb 22, 2022 07:00AM Oyster Point Pharma Announces TYRVAYA™ Nasal Spray Now Covered by Express Scripts
Feb 22, 2022 07:00AM Oyster Point Pharma Announces TYRVAYA™ Nasal Spray Now Covered by Express Scripts
View More Recent Stories View Older Stories